Sana Biotechnology (SANA) Shares Outstanding (2020 - 2026)

Sana Biotechnology has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $269.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 19.67% year-over-year to $269.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $269.8 million (up 19.67% YoY) and the FY2025 annual result came in at $266.7 million, up 19.12% from the prior year.
• Shares Outstanding (Entity) improved to $269.8 million in Q1 2026 per SANA's latest filing, from $266.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $269.8 million in Q1 2026 and troughed at $186.6 million in Q1 2022.
• A 5-year average of $216.7 million and a median of $221.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) jumped 56.66% in 2022, then grew 1.89% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $191.0 million in 2022, then rose by 3.58% to $197.9 million in 2023, then rose by 13.17% to $223.9 million in 2024, then climbed by 19.12% to $266.7 million in 2025, then climbed by 1.16% to $269.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $269.8 million, $266.7 million, and $262.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.